JPH0425264B2 - - Google Patents

Info

Publication number
JPH0425264B2
JPH0425264B2 JP58073470A JP7347083A JPH0425264B2 JP H0425264 B2 JPH0425264 B2 JP H0425264B2 JP 58073470 A JP58073470 A JP 58073470A JP 7347083 A JP7347083 A JP 7347083A JP H0425264 B2 JPH0425264 B2 JP H0425264B2
Authority
JP
Japan
Prior art keywords
group
compound
reaction
acid
azetidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58073470A
Other languages
English (en)
Japanese (ja)
Other versions
JPS591465A (ja
Inventor
Michihiko Ochiai
Taisuke Matsuo
Shoji Kishimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of JPS591465A publication Critical patent/JPS591465A/ja
Publication of JPH0425264B2 publication Critical patent/JPH0425264B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58073470A 1982-04-27 1983-04-25 ４―シアノ―２―アゼチジノン誘導体の製造法 Granted JPS591465A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MC82/00141 1982-04-27
PCT/JP1982/000141 WO1983003827A1 (en) 1982-04-27 1982-04-27 4-cyano-2-azetidinone derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
JPS591465A JPS591465A (ja) 1984-01-06
JPH0425264B2 true JPH0425264B2 (sv) 1992-04-30

Family

ID=13762237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58073470A Granted JPS591465A (ja) 1982-04-27 1983-04-25 ４―シアノ―２―アゼチジノン誘導体の製造法

Country Status (3)

Country Link
JP (1) JPS591465A (sv)
NZ (1) NZ202907A (sv)
WO (1) WO1983003827A1 (sv)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846066A (ja) * 1981-08-27 1983-03-17 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト β−ラクタム類

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846066A (ja) * 1981-08-27 1983-03-17 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト β−ラクタム類

Also Published As

Publication number Publication date
WO1983003827A1 (en) 1983-11-10
NZ202907A (en) 1986-01-24
JPS591465A (ja) 1984-01-06

Similar Documents

Publication Publication Date Title
EP0053816B1 (en) 1-sulfo-2-oxoazetidine derivatives, their production and use
JPH0670006B2 (ja) ベータラクタム抗生物質中間体
JPH0333154B2 (sv)
EP0021678A1 (en) 1-Sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
EP0053815B1 (en) 2-oxoazetidine derivatives, their production and use
EP0093376B2 (en) 1-Sulfo-2-azetidinone derivatives, their production and use
US4683303A (en) Reduction process for the preparation of 4-unsubstituted azetidin-2-ones
EP0083039B1 (en) 4-cyano-2-azetidinones and production thereof
JPH0830051B2 (ja) ４−ハロゲノ−２−置換オキシイミノ−３−オキソ酪酸のエステルまたはアミドの製造法
JPH0425264B2 (sv)
US4416817A (en) 3-Methoxy-2-oxoazetidine derivatives and their production
JPH0424347B2 (sv)
US4533495A (en) Method of producing 2-azetidinone-1-sulfonic acid compounds
US5821362A (en) Method of desilylating silylether compounds
JPS641468B2 (sv)
KR880000874B1 (ko) 1-술포-2-옥소아제티딘 유도체의 제조방법
JPS641467B2 (sv)
KR890000226B1 (ko) 1-술포-2-옥소아제티딘 유도체의 제조방법
JPH0435477B2 (sv)
JPH0463066B2 (sv)
JPS63107977A (ja) イソオキサゾロン誘導体
EP0053387A1 (en) Method of preparing 1-sulfo-2-oxoazetidine derivatives and intermediates therefor
JPH05331175A (ja) 新規なセファロスポリン誘導体およびその塩
JPH0329794B2 (sv)
JPS6126536B2 (sv)